secwatch.observer — SEC 8-K summary
======================================

Issuer:     MEDIFAST INC (MED)
CIK:        0000910329
Form:       8-K
Filed at:   2026-07-17T12:33:58+00:00
Accession:  0001628280-26-048574
Event type: other_material
Sentiment:  positive
Materiality: 0.65
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Medifast rebrands OPTAVIA to Trilivy, launches metabolic health system with new products
--------------------------------------------------------------------------------

- New brand Trilivy replaces OPTAVIA, expanding from weight loss to metabolic health for over 90% of U.S. adults.
- Trilivy Reset Fueling line with MetaVantage Technology aims to optimize metabolism and reduce waist circumference.
- Clinical data: 14% reduction in visceral fat in 16 weeks and 98% lean mass retention during weight loss.
- Three-phase system: Reset (reverse metabolic dysfunction), Refine, Renew to support healthspan.
- Newly formulated Fuelings to debut in August 2026; coach-supported program shows up to 10x more weight loss.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/910329/000162828026048574/0001628280-26-048574-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/910329/000162828026048574/med-20260717.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-048574

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer